thalidomide has been researched along with neopterin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlin, E; Cookson, S; Dalgleish, AG; Gazzard, B; Hawkins, DA; Marriott, JB; Nelson, M; Pearson, M; Vaughan, AN; Youle, M | 1 |
Drenth, JP; Powell, R; Simon, A; van der Meer, JW; Vonk, AG | 1 |
Abalos, RM; Balagon, MV; Cellona, RV; Fajardo, TT; Kook, KA; Palmer, JP; Tan, EV; Thomas, SD; Villahermosa, LG; Walsh, DS; Walsh, GP; Wittes, J | 1 |
3 trial(s) available for thalidomide and neopterin
Article | Year |
---|---|
A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokines.
Topics: Adult; Anti-HIV Agents; Antigens, CD; beta 2-Microglobulin; Biomarkers; CD4 Antigens; CD8 Antigens; Cytokines; Double-Blind Method; Follow-Up Studies; HIV Seropositivity; Humans; Interferon-gamma; Interleukin-10; Interleukin-4; Male; Neopterin; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Thalidomide; Tumor Necrosis Factor-alpha | 1997 |
Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.
Topics: Acute-Phase Reaction; Adult; Cross-Over Studies; Cytokines; DNA Mutational Analysis; Double-Blind Method; Female; Fever; Humans; Immune System Diseases; Immunoglobulin D; Immunosuppressive Agents; Male; Middle Aged; Neopterin; Recurrence; Syndrome; Thalidomide; Treatment Outcome | 2001 |
A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Erythema Nodosum; Humans; Interleukin-6; Leprostatic Agents; Leprosy, Lepromatous; Lymphocytes; Male; Middle Aged; Neopterin; Thalidomide; Tumor Necrosis Factor-alpha | 2005 |